Loading...
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
Ulcerative colitis (UC) still has no definitive cure since its etiology remains unclear. In recent years, considerable progress has been made with regard to our knowledge of the pathogenesis of UC. Advances in biotechnology have led to the development of biologic therapies which selectively target s...
Na minha lista:
| Udgivet i: | Biologics |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6497489/ https://ncbi.nlm.nih.gov/pubmed/31114154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S179006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|